National and Kapodistrian University of Athens
Έκφραση μορίων του κυτταρικού κύκλου στη νόσο του Hodgkin
Abstract
dc:descriptionBACKGROUND: Several biological markers have been reproducibly associated with HL patients’ prognosis, nevertheless not been incorporated into current prognostic systems. Inferior prognosis has been correlated with increased neoplastic cells’ proliferation rate (mainly reflected by Ki67 or PCNA expression) but the issue still remains controversial. Minichromosome maintenance proteins (MCMs) are essential for the formation of the prereplicative complexes, which is the first key event during G1 phase. D-type Cyclins, in conjunction with CDK4/6 operate late G1 phase to promote progression through the G1/S restriction point. PURPOSE: (1) To study the expression of the proliferation molecules CCND3, MCM2 and MCM7 by HRS cells in a relatively large series of homogeneously treated HL patients and (2) to investigate the correlation between their expression with demographic, clinical, laboratory and histopathological parameters, as well as patients’ outcome MATERIAL & METHODS: Lymph node sections from 138 HIV-negative HL – patients, >14 years old, were immunohistochemically stained for CCND3, MCM2, MCM7 and Ki67. Stained slides were evaluated by image analysis. RESULTS: MCM2 was expressed in 115/116 cases in a median of 63% of HRS cells (0-99); MCM7 in 121/121 cases (median 88% of HRS cells, range 15- 100; CCND3 in 105/113 cases (median 24%, range 0-98). There was a relatively strong positive correlation between MCM2 and MCM7 (Spearman’s rho 0.28, p=0.004), but MCM2 and 7 were not correlated with CCND3 or Ki67. Higher MCM2 expression was observed in patients with early stages (p=0.03), lower leukocyte counts (p=0.03) and higher albumin levels (p=0.002). Higher MCM7 expression was observed in asymptomatic patients (p=0.004), in early stages (p=0.005), <5 involved sites (p=0.009), no anemia (p=0.02) and higher albumin levels (p=0.005). Higher CCND3 expression was observed in older patients (p=0.03) with lower leukocyte counts (p=0.05) and normal LDH (p=0.05). At any cutoff examined, MCM2, MCM7 and CCND3 expression was not correlated with 142 failure free (FFS) or overall survival (OS) in univariate analysis. However, multivariate analysis revealed that higher MCM7 expression was an adverse prognostic factor for OS along with age and advanced stage and had a borderline effect on FFS, when adjusted for stage. CONCLUSIONS: Our data suggest that MCM2, MCM7 and CCND3 are expressed by the HRS cells in the majority of HL patients. MCM2 and MCM7 are interrelated, but not correlated with CCND3 or Ki67. Interestingly, MCM2 and MCM7 expression was higher in patients with markers of less extensive or less aggressive disease. For this reason, although not associated with the outcome in univariate analysis, higher MCM7 expression emerged as an adverse prognostic factor in multivariate analysis. Thus MCM7 expression appears to deserve further evaluation in larger patient serie
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Marnerides, Andreas
- Μαρνερίδης, Ανδρέας
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25397